M. M. Dar, W. Gulzar, A. A. Paray, and M. S. Javid, “Metabolic, neurological and endocrine safety profiles of atypical antipsychotics: focus on quetiapine, olanzapine and risperidone: an updated review”, Int J Res Med Sci, vol. 14, no. 4, pp. 1738–1749, Mar. 2026.